- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02569840
Amino Acid Feed Children's Study
An Evaluation of the Tolerance and Acceptability of Neocate Junior an Amino Acid Based Formula for Children
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Dietary management of Cows' Milk Allergy (CMA) involves avoiding cow's milk protein in the diet, whilst ensuring that an adequate nutritional intake is achieved with suitable alternative foods or prescribable feeds. A number of studies and clinical insights indicate that CMA is persisting longer than infancy, into later childhood and becoming more complex. If a child has CMA, eliminating the offending allergens whilst maintaining an intake of food that meets their nutritional requirements for growth and development is challenging due to the significant nutritional contribution these foods make to a child's diet, particularly milk and dairy products. This supports the need for alternatives to cow's milk to be available for children >1year of age to help meet their nutritional needs. Aminoacid based feeds are already widely used in clinical practice to meet this need. A new nutritionally complete amino acid based powdered feed for the dietary management of CMA, or other conditions where an amino acid based is recommended, in children aged 1-10yrs old, has been developed.
This study is to support the use of this new amino acid based feed in clinical practice. The study will evaluate the tolerance and acceptability of the amino acid based powdered feed in 20 children aged 1-10yrs of age receiving or requiring an amino acid based feed for the dietary management of CMA and food allergy associated conditions, over 4 weeks. The primary outcome will be gastrointestinal tolerance, with secondary outcomes of compliance, acceptability, nutrient intake and anthropometry.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Male or female
- Age 1-10 years
- Currently using or requiring an amino acid based feed
- Expected to receive at least 30% of their energy intake from the study product
- Written informed consent from parents / carer
Exclusion Criteria:
- Parenteral nutrition contributing more than 70% of total energy intake
- Children with major hepatic or renal dysfunction
- Participation in other studies within 2 weeks prior to entry of this study
- Investigator concern around willingness/ability of parent/carer to comply with protocol requirements
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Andet: Amino Acid Feed
An amino acid based multi-nutrient powdered feed
|
Each child will receive the amino acid based feed for a period of up to 4 weeks (28 days).
The feed prescription will be determined on an individual basis by the Dietitian responsible for the child's nutritional management.
The child will take the feed orally or via a pre-existing naso-gastric, gastrostomy or jejunostomy tube.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Gastro intestinal tolerance questionnaire
Tidsramme: 4 weeks
|
Gastro-intestinal tolerance will be recorded at baseline and on days 1, 2, 3 and 7 of week 1 of the study.
During weeks 2 and 3 tolerance will be recorded once at the end of each week on days 14 and 21.
During week 4, tolerance will be recorded on days 26, 27 and 28.
Tolerance will be recorded using a standardised gastro-intestinal tolerance questionnaire, to be completed by the parents/carer
|
4 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Compliance with feed prescription (amount prescribed versus consumed)
Tidsramme: 4 weeks
|
Compliance with feed prescription will be assessed daily throughout the study by recording how much feed was received, to be recorded by the parents/carer.
The amount prescribed by the Dietitian will be recorded at the start of the study, and any changes to this prescription also noted
|
4 weeks
|
Product acceptability questionnaire
Tidsramme: 4 weeks
|
Feed acceptability (ease of use) will be assessed at the end of week 4 by questionnaire completed by the parents/carer.
|
4 weeks
|
Nutrient intake (energy, protein and micronutrients)
Tidsramme: 4 weeks
|
Nutrient intake, including the intake of all nutrition provided (including the study product, any parenteral feeding, other enteral tube feeding, foods, drinks etc) will be recorded at baseline and on Day 28 by the Dietitian using 24hour recall, and then in 3 day food diaries at baseline (Days 1, 2 and 3) and Week 4 (Days 26, 27 and 28) by the parent/carer.
A dietary analysis program will be used to calculate total dietary intake
|
4 weeks
|
Weight (kg)
Tidsramme: 4 weeks
|
For safety purposes, at baseline and at the end of week 4, body weight (kg) will be measured where possible using standard methods, to the nearest 0.1kg using a weighing scale without heavy clothing.
Height will also be measured, wherever possible, using standard measures to the nearest 0.1cm.
For children up to 2yrs of age, head circumference will be measured where possible, using standard methods to the nearest 0.1cm
|
4 weeks
|
Height (cm)
Tidsramme: 4 weeks
|
For safety purposes, at baseline and at the end of week 4, body weight (kg) will be measured where possible using standard methods, to the nearest 0.1kg using a weighing scale without heavy clothing.
Height will also be measured, wherever possible, using standard measures to the nearest 0.1cm.
For children up to 2yrs of age, head circumference will be measured where possible, using standard methods to the nearest 0.1cm
|
4 weeks
|
Head circumference (cm)
Tidsramme: 4 weeks
|
For safety purposes, at baseline and at the end of week 4, body weight (kg) will be measured where possible using standard methods, to the nearest 0.1kg using a weighing scale without heavy clothing.
Height will also be measured, wherever possible, using standard measures to the nearest 0.1cm.
For children up to 2yrs of age, head circumference will be measured where possible, using standard methods to the nearest 0.1cm
|
4 weeks
|
Safety by Adverse Event reporting
Tidsramme: 4 weeks
|
All adverse events will be recorded, throughout the study.
|
4 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- NJ002
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Overfølsomhed over for mælk
-
USDA, Western Human Nutrition Research CenterUniversity of Copenhagen; Bill and Melinda Gates Foundation; International... og andre samarbejdspartnereRekrutteringHuman Milk Nutrient Reference VærdierDanmark, Bangladesh, Brasilien, Gambia
-
Nutricia ResearchAktiv, ikke rekrutterendeVækst | Tolerance | Sikkerhed | Emner, der har brug for en Human Milk Fortifier (HMF)Holland, Frankrig, Tyskland, Det Forenede Kongerige
Kliniske forsøg med Amino Acid Feed
-
University of California, Los AngelesAfsluttetGlucoseintolerance | Overvægtige | Præ-diabetesForenede Stater
-
University of Colorado, DenverAfsluttetFedme | Polycystisk ovariesyndrom | Hepatisk SteatoseForenede Stater
-
McMaster UniversityAjinomoto USA, INC.AfsluttetPsykologiske fænomener: Central træthedCanada
-
Western Regional Medical CenterTrukket tilbageKræft kakeksi
-
The Netherlands Cancer InstituteUMC UtrechtAfsluttetKræftgenetik | Psykosociale problemerHolland
-
Northumbria UniversityAfsluttetTrænings-induceret muskelskade
-
Post Graduate Institute of Medical Education and...All India Institute of Medical Sciences, Bhubaneswar; Asian Institute of... og andre samarbejdspartnereRekrutteringAkut-på-kronisk leversvigt | Hepatisk encefalopatiIndien
-
Rigshospitalet, DenmarkAfsluttetLevercirrhose | Hepatisk encefalopati | SøvnforstyrrelserDanmark
-
Arkansas Children's Hospital Research InstituteAktiv, ikke rekrutterendeVækstsvigt | Ernæringsmæssig hæmningForenede Stater
-
University of OxfordIkke rekrutterer endnuParkinsons sygdom | Dystoni | RystenDet Forenede Kongerige